Q2 revenue rises 24% as Healthcare grows 78%
SHAILY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.0 pts more than its Plastic Products - Consumer peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 FY27 revenue rose 24% to INR320 crore and EBITDA rose 25% to INR102 crore, with margin at 31.9%. Profit after tax was INR61 crore. Healthcare revenue jumped 78% to INR175 crore and formed 55% of sales, while Consumer fell 14%. Management expects FY27 device deliveries above 36 million. Two platform contracts were signed, with product confirmations in Consumer and Industrial. Electronics and semiconductor expansion is planned over 36 months.
Record revenue, led by Healthcare, may support the stock, but weak Consumer demand, price pressure and expansion spending could weigh on returns.